Skip to content

MondayNightIBD | Medication Safety During Pregnancy  | November 14, 2022 - Joshua Steinberg, MD *Post-test*

In order to receive credit for this activity, you must read the front matter, view the activity, complete the post-survey, as well as complete the linked evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements. 

There is no fee to participate in this activity.
1.Where are you in your career?(Required.)
2.32 y/o woman with Crohns ileocolitis in remission on UST SQ every 8 weeks is here to discuss pregnancy. Her last colonoscopy was 6 months ago and showed endoscopic healing. What is the recommendation you make to her to optimize pregnancy outcome?
3.Which of the following statements about biologics during pregnancy is true ?
EVALUATION FORM
4.Upon completion of this activity, I am able to:
Strongly agree
Agree
Disagree
Strongly disagree
IDENTIFY guideline-directed strategies and best practices for the care of patients with IBD
ANALYZE potential approaches for positioning new and emerging therapies for UC
EVALUATE complex clinical situations in which patients with IBD may benefit from management strategies including novel therapeutics
5.Please indicate the extent of your agreement with the following statements:
Strongly agree
Agree
Disagree
Strongly disagree
The faculty for this activity were effective
The educational resources and/or handouts provided to me at the educational activity are useful to my practice
6.Overall, was this activity fair, balanced and free from commercial bias?
7.If no, please explain:
8.Of the patients you will see in the next month, about how many will benefit from the information you learned today?
9.I will make the following changes to my practice based on what I learned today (check all that apply):
10.Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):
11.For purposes of certification, please complete the following information. *Please note that we will not forward or sell your contact information.*(Required.)
12.I certify that I have participated in the continuing education activity entitled, "MondayNightIBD | Medication Safety During Pregnancy " and claim 1.0 AMA PRA Category 1 CreditTM.(Required.)
Thank you for participating in our activity and completing the necessary paperwork. Your certificate will be emailed to you using the email address provided above. Please allow 4 weeks to receive your certificate. 

For information about the certification of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Privacy & Cookie Notice